Mel Evans is a Partnerships and Projects Editor at Metro.co.uk. With a focus on local news in the United Kingdom, Mel's articles cover a range of topics including sports, lifestyle, health, and current events. Their work has also been featured in various publications such as Rutgers University, Lufkin Daily Newspaper, and CATHOLICS & FRIENDS WITH A HEART.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United Kingdom (National)
Not enough data
Mel Evans's articles focus mainly on local entertainment, Black Friday deals, and lifestyle topics. She reports on breaking news, promotional deals, evolving stories, and event coverage. If you are looking to reach out to her for potential coverage or collaboration, consider providing information related to local entertainment events in the United Kingdom or exclusive insights into Black Friday deals and trends that would appeal to a UK audience. Additionally, pitches related to skincare products or daily competitions with a unique angle could also capture her interest.
Regarding geographic focus specifically targeting the UK region would likely resonate well with Mel Evans due to her localized reporting style.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Mel Evans
We have our three controversial finalists.
Fancy a buddymoon? I do!
FILE - Cooper University Hospital board chairman George Norcross III listens in Camden, N.J., May 15, 2012, during a groundbreaking ceremony for the Cooper Cancer Institute. New Jersey's attorney general
By: Mel Evans
Don't get me out of here!
By: Mel Evans, Katarina Vojvodic
Bally's, the sole RI online casino operator, generated nearly $2.3M in May in adjusted gross revenue, the Rhode Island Lottery reported.
By Frank Bonner II, Daily Memphian Updated: July 22, 2024 9:00 PM CT | Published: July 22, 2024 8:58 PM CT
By: Rebecca Sayce, Mel Evans
They have quite the history.
By: Taylor O'Bier
Novo Nordisk, the maker of Ozempic and Wegovy, said its experimental weight-loss pill lowered participants' body weight by up to 13% after three months of its Phase 1 clinical trial.
Trust us, they're like walking on marshmallows.
By: Mel Evans
The beauty industry sucked me right in.
(833) 317-6278 
